FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to the pharmaceutical industry and is a stable composition for silybin-based injections, characterized by that it contains silybin, sulphobutyl ether β-cyclodextrin, an organic solvent for injections, a co-solvent and a pH regulator, wherein the pH value is adjusted to 2.0–8.0.
EFFECT: invention provides a safe and stable composition for silybin-based injections.
17 cl, 6 tbl, 6 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| IRINOTECAN LIPOSOMES OR ITS SALTS, METHOD FOR PREPARING THEM | 2009 |
|
RU2526114C2 |
| PHARMACEUTICAL COMPOSITION | 2003 |
|
RU2313346C2 |
| LYOPHILISED PREPARATION OF CYTOTOXIC DIPEPTIDES | 2012 |
|
RU2597154C2 |
| METHOD FOR OBTAINING SUSPENSION CONTAINING NANOSIZED PARTICLES OF DRUG | 2020 |
|
RU2756757C1 |
| COMPOSITION FOR INJECTION BASED ON A FAT EMULSION OF CABAZITAXEL, A METHOD FOR ITS PREPARATION AND APPLICATION | 2016 |
|
RU2716218C2 |
| LIPOSOME HAVING INNER AQUEOUS PHASE AND CONTAINING SULPHOBUTYL ESTER CYCLODEXTRIN SALT | 2010 |
|
RU2575793C2 |
| LIPOSOMAL COMPOSITIONS CONTAINING SLIGHTLY ACIDIC DRUGS, AND THEIR USE | 2018 |
|
RU2778886C2 |
| COMPOSITIONS WHICH CONTAIN EPOTHILONE, AND METHOD OF THEIR OBTAINING | 2005 |
|
RU2416407C2 |
| PHARMACEUTICAL COMPOSITION FOR CONTROLLED RELEASE OF WEAK ACID DRUGS AND ITS USE | 2019 |
|
RU2810790C2 |
| AQUEOUS PHARMACEUTICAL COMPOSITIONS BASED ON 1,2-DIHYDROPYRIDINE COMPOUNDS | 2019 |
|
RU2824582C2 |
